Articles by this author:
- mHealth apps foster drug adherence (Exclusive News Alert, In this Issue, Retail News, Category Reviews, Locked, Collaborative Care, Pharmacy)Mon, 11/17/2014 - 6:46pm
mHealth — the use of mobile technology devices and smartphones for healthcare purposes — is transforming health care as more Americans adopt mobile devices.
Last year, Drug Store News covered extensively the results from Thrifty White's successful medication synchronization program. DSN recently checked in with Tim Weippert, Thrifty White EVP pharmacy, to get an update.
Drug Store News caught up with Upsher-Smith chief commercial officer Rusty Field to discuss topiramate extended-release capsules, its new authorized generic to Qudexy XR.
DSN spoke with Neas in late October to mark the 30th anniversary of the landmark Drug Price Competition and Patent Term Restoration Act — better known as the Hatch-Waxman Act.
Thirty years ago, Democratic and Republican members of Congress hammered out a rare and prescient bipartisan compromise bill that transformed the pharmaceutical landscape forever and unleashed the modern generic drug industry. That law, known as the Hatch-Waxman Act, has proven to be one of the most far-reaching and impactful pieces of legislation ever to shape the American healthcare system.
Could the regulatory and scientific logjam that’s keeping copycat biotech medicines off the market and out of the hands of patients and health providers in the United States finally be breaking?